Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Current Opinion in Rheumatology
|
August 4, 2018
Advances in the early diagnosis and therapy of inclusion body myositis
James B Lilleker
Best Practice & Research. Clinical Rheumatology
|
February 18, 2020
Pitfalls in the diagnosis of myositis
Hector Chinoy, James B Lilleker
Rheumatic Diseases Clinics of North America
|
October 29, 2025
Emerging Treatment Options for Inclusion Body Myositis
James B Lilleker, Stefen Brady
Clinical and Experimental Rheumatology
|
February 24, 2022
The perils of myositis mimickers with illustrative case reports
Italo Marago, James B Lilleker, Hector Chinoy
Seizure
|
May 20, 2014
Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications
James B Lilleker, Viveka Biswas, Rajiv Mohanraj
Current Opinion in Rheumatology
|
September 17, 2020
Cardiac involvement in inflammatory myopathies and inherited muscle diseases
James B Lilleker, Mark Roberts, Louise Diederichsen
Current Opinion in Rheumatology
|
August 5, 2017
Genetics in inclusion body myositis
Simon Rothwell, James B Lilleker, Janine A Lamb
Seizure
|
July 11, 2013
VGKC complex antibodies in epilepsy: diagnostic yield and therapeutic implications
James B Lilleker, Matthew S Jones, Rajiv Mohanraj
Neurologia I Neurochirurgia Polska
|
January 8, 2018
A missense mutation in DYNC1H1 gene causing spinal muscular atrophy - Lower extremity, dominant
Joyutpal Das, James B Lilleker, Kavaldeep Jabbal, et al.
Annals of the Rheumatic Diseases
|
March 4, 2015
Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity
Michael Hughes, James B Lilleker, Ariane L Herrick, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Current Opinion in Rheumatology
|
August 4, 2018
Advances in the early diagnosis and therapy of inclusion body myositis
James B Lilleker
Best Practice & Research. Clinical Rheumatology
|
February 18, 2020
Pitfalls in the diagnosis of myositis
Hector Chinoy, James B Lilleker
Rheumatic Diseases Clinics of North America
|
October 29, 2025
Emerging Treatment Options for Inclusion Body Myositis
James B Lilleker, Stefen Brady
Clinical and Experimental Rheumatology
|
February 24, 2022
The perils of myositis mimickers with illustrative case reports
Italo Marago, James B Lilleker, Hector Chinoy
Seizure
|
May 20, 2014
Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications
James B Lilleker, Viveka Biswas, Rajiv Mohanraj
Current Opinion in Rheumatology
|
September 17, 2020
Cardiac involvement in inflammatory myopathies and inherited muscle diseases
James B Lilleker, Mark Roberts, Louise Diederichsen
Current Opinion in Rheumatology
|
August 5, 2017
Genetics in inclusion body myositis
Simon Rothwell, James B Lilleker, Janine A Lamb
Seizure
|
July 11, 2013
VGKC complex antibodies in epilepsy: diagnostic yield and therapeutic implications
James B Lilleker, Matthew S Jones, Rajiv Mohanraj
Neurologia I Neurochirurgia Polska
|
January 8, 2018
A missense mutation in DYNC1H1 gene causing spinal muscular atrophy - Lower extremity, dominant
Joyutpal Das, James B Lilleker, Kavaldeep Jabbal, et al.
Annals of the Rheumatic Diseases
|
March 4, 2015
Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity
Michael Hughes, James B Lilleker, Ariane L Herrick, et al.
Page
of 10